Increased mitogen-induced lymphocyte proliferation in treatment resistant depression: a preliminary study

Neuro Endocrinol Lett. 2004 Jun;25(3):207-10.

Abstract

Background: The biological basis of treatment resistance in depression still remains unclear. Some studies suggest that there exists a relationship between a disturbance in the immune system and depression.

Aims: To investigate the immune status of patients with treatment resistant depression, we compared the in-vitro lymphocytic responses to three different mitogens in 10 drug-free patients with treatment resistant depression and 10 normal controls matched for age and sex.

Results: We observed a marked increase in the lymphocyte mitogenic activity to mitogens of T lymphocytes.

Discussion: This activation of lymphocyte function may be indicative of a pathological stimulation in cell-mediated immunity in patients with treatment resistant depression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Concanavalin A / pharmacology
  • Depression / immunology*
  • Depressive Disorder / immunology
  • Female
  • Humans
  • Lymphocyte Activation / drug effects*
  • Male
  • Middle Aged
  • Mitogens / pharmacology*
  • Phytohemagglutinins / pharmacology
  • Reference Values
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*

Substances

  • Mitogens
  • Phytohemagglutinins
  • phytohemagglutinin-P
  • Concanavalin A